Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
GI Cancers May 2015 This bulletin covers aspects of esophageal, gastric, intestinal and colorectal cancers and should be of interest to multidisciplinary teams working in this area. Sections can include: Combined Modality Therapies Drug and Targeted Therapies Pathology, Staging, Polymorphisms & Biomarkers Prognosis, Survival & Risk Factors Radiotherapy & Imaging Supportive Care & Symptom Management Surgery Many of the following articles are available online via the NHS Scotland Knowledge Network. Please use the links where provided and your ATHENS password. A complete list of available online journals and registration for ATHENS can be found at www.knowledge.scot.nhs.uk/ If the article you require is not available via the NHS Scotland Knowledge Network and you would like to request a print copy, please submit your request online at www.quest.scot.nhs.uk This bulletin contains a selection of material gathered from a search of the evidence base, and is not intended to be comprehensive. Professional judgment should be exercised when appraising the material. The Library takes no responsibility for the wording, content and accuracy of the information supplied, which has been extracted in good faith from reputable sources. NHSGGC is not responsible for the content of external internet sites. Compiled by: Kirsty Coltart Subject Librarian Beatson West of Scotland Cancer Centre 0141 301 7285, [email protected] General Abunassar M, Reinders J, Jonker DJ, et al. (2015). Review of anal cancer patients at the Ottawa hospital. European Journal of Surgical Oncology 41,5:653-658. Bauer K, Schroeder M, Porzsolt F, et al. (2015). Comparison of international guidelines on the accompanying therapy for advanced gastric cancer: reasons for the differences. Journal of Gastric Cancer 15,1:10-18. Brannstrom F, Bjerregaard JK, Winbladh A, et al. (2015). Multidisciplinary team conferences promote treatment according to guidelines in rectal cancer. Acta Oncologica 54,4:447-453. Cools-Lartigue J, Spicer J and Ferri LE. (2015). Current status of management of malignant disease: current management of esophageal cancer. Journal of Gastrointestinal Surgery 19,5:964-972. Ghosn M, Kourie HR, Abdayem P, et al. (2015). Anal cancer treatment: current status and future perspectives. World Journal of Gastroenterology 21,8:2294-2302. Harlan LC, Eisenstein J, Russell MC, et al. (2015). Gastrointestinal stromal tumors: Treatment patterns of a population-based sample. Journal of surgical oncology 111,6:702707. Onyeuku NE, Ayala-Peacock DN, Russo SM, et al. (2015). The multidisciplinary approach to the treatment of rectal cancer: 2015 update. Expert review of gastroenterology & hepatology 9,4:507-517. Papamichael D, Audisio RA, Glimelius B, et al. (2015). Treatment of colorectal cancer in older patients: International Society of Geriatric Oncology (SIOG) consensus recommendations 2013. Annals of Oncology 26,3:463-476. Shridhar R, Shibata D, Chan E, et al. (2015). Anal cancer: current standards in care and recent changes in practice. CA: a Cancer Journal for Clinicians 65,2:139-162. Stordeur S, Vlayen J, Vrijens F, et al. (2015). Quality indicators for oesophageal and gastric cancer: a population-based study in Belgium, 2004-2008. European Journal of Cancer Care 24,3:376-386.. Combined Modality Therapies Breugom AJ, van Gijn W, Muller EW, et al. (2015). Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial+. Annals of Oncology 26,4:696-701. Cai G, Zhu J, Palmer JD, et al. (2015). CAPIRI-IMRT: a phase II study of concurrent capecitabine and irinotecan with intensity-modulated radiation therapy for the treatment of recurrent rectal cancer. Radiation Oncology 10,1:57. Dai T and Shah MA. (2015). Chemoradiation in oesophageal cancer. Best Practice & Research in Clinical Gastroenterology 29,1:193-209. Garcia M, Martinez-Villacampa M, Santos C, et al. (2015). Phase II study of preoperative bevacizumab, capecitabine and radiotherapy for resectable locally-advanced rectal cancer. BMC Cancer 15,59. 2 GI Cancers, February 2015 Kirsty Coltart, Subject Librarian, NHSGGC Library Network Marinello FG, Frasson M, Baguena G, et al. (2015). Selective approach for upper rectal cancer treatment: total mesorectal excision and preoperative chemoradiation are seldom necessary. Diseases of the Colon & Rectum 58,6:556-565. Petrelli F, Coinu A, Lonati V, et al. (2015). A systematic review and meta-analysis of adjuvant chemotherapy after neoadjuvant treatment and surgery for rectal cancer. International journal of colorectal disease 30,4:447-457. Pezzolo E, Modena Y, Corso B, et al. (2015). Germ line polymorphisms as predictive markers for pre-surgical radiochemotherapy in locally advanced rectal cancer: a 5-year literature update and critical review. European journal of clinical pharmacology 71,5:529-539. Robb WB, Dahan L, Mornex F, et al. (2015). Impact of Neoadjuvant Chemoradiation on Lymph Node Status in Esophageal Cancer: Post hoc Analysis of a Randomized Controlled Trial. Annals of Surgery 261,5:902-908. Salazar R, Capdevila J, Laquente B, et al. (2015). A randomized phase II study of capecitabine-based chemoradiation with or without bevacizumab in resectable locally advanced rectal cancer: clinical and biological features. BMC Cancer 15,60. Drug & Targeted Therapies Berger AK, Zschaebitz S, Komander C, et al. (2015). Palliative chemotherapy for gastroesophageal cancer in old and very old patients: A retrospective cohort study at the National Center for Tumor Diseases, Heidelberg. World Journal of Gastroenterology 21,16:4911-4918. Berry SR, Cosby R, Asmis T, et al. (2015). Continuous versus intermittent chemotherapy strategies in metastatic colorectal cancer: a systematic review and meta-analysis. Annals of Oncology 26,3:477-485. Di Bartolomeo M, Ciarlo A, Bertolini A, et al. (2015). Capecitabine, oxaliplatin and irinotecan in combination, with bevacizumab (COI-B regimen) as first-line treatment of patients with advanced colorectal cancer. An Italian Trials of Medical Oncology phase II study. European journal of cancer 51,4:473-481. Garcia-Alfonso P, Chaves M, Munoz A, et al. (2015). Capecitabine and irinotecan with bevacizumab 2-weekly for metastatic colorectal cancer: the phase II AVAXIRI study. BMC Cancer 15,1:327. Gruenberger T, Bridgewater J, Chau I, et al. (2015). Bevacizumab plus mFOLFOX-6 or FOLFOXIRI in patients with initially unresectable liver metastases from colorectal cancer: the OLIVIA multinational randomised phase II trial. Annals of Oncology 26,4:702-708. Kataoka K, Tsushima T, Mizusawa J, et al. (2015). A randomized controlled Phase III trial comparing 2-weekly docetaxel combined with cisplatin plus fluorouracil (2-weekly DCF) with cisplatin plus fluorouracil (CF) in patients with metastatic or recurrent esophageal cancer: rationale, design and methods of Japan Clinical Oncology Group study JCOG1314 (MIRACLE study). Japanese journal of clinical oncology 45,5:494-498. Katayose Y, Yamamoto K, Nakagawal K, et al. (2015). Feasibility Assessment of Modified FOLFOX-6 as adjuvant treatment after resection of liver metastases from colorectal cancer: analyses of a multicenter phase II clinical trial (Miyagi-HBPCOG Trial-001). Hepato-gastroenterology 62,138:303-308. 3 GI Cancers, February 2015 Kirsty Coltart, Subject Librarian, NHSGGC Library Network Koeberle D, Betticher DC, von Moos R, et al. (2015). Bevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06). Annals of Oncology 26,4:709-714. Masi G, Salvatore L, Boni L, et al. (2015). Continuation or reintroduction of bevacizumab beyond progression to first-line therapy in metastatic colorectal cancer: final results of the randomized BEBYP trial. Annals of Oncology 26,4:724-730. Nishikawa K, Fujitani K, Inagaki H, et al. (2015). Randomised phase III trial of second-line irinotecan plus cisplatin versus irinotecan alone in patients with advanced gastric cancer refractory to S-1 monotherapy: TRICS trial. European journal of cancer 51,7:808-816. Petrelli F, Coinu A, Ghilardi M, et al. (2015). Efficacy of Oxaliplatin-based Chemotherapy+Bevacizumab as First-line Treatment for Advanced Colorectal Cancer: A Systematic Review and Pooled Analysis of Published Trials. American Journal of Clinical Oncology 38,2:227-233. Poulsen LO, Qvortrup C, Pfeiffer P, et al. (2015). Review on adjuvant chemotherapy for rectal cancer - why do treatment guidelines differ so much?. Acta Oncologica 54,4:437446. Ryu MH, Yoo C, Kim JG, et al. (2015). Multicenter phase II study of trastuzumab in combination with capecitabine and oxaliplatin for advanced gastric cancer. European journal of cancer 51,4:482-488. Wade R, Duarte A, Simmonds M, et al. (2015). The Clinical and Cost Effectiveness of Aflibercept in Combination with Irinotecan and Fluorouracil-Based Therapy (FOLFIRI) for the Treatment of Metastatic Colorectal Cancer Which has Progressed Following Prior Oxaliplatin-Based Chemotherapy: a Critique of the Evidence. PharmacoEconomics 33,5:457-466. Xu HB, Huang F, Su R, et al. (2015). Capecitabine plus oxaliplatin (XELOX) compared with 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOXs) in advanced gastric cancer: metaanalysis of randomized controlled trials. European journal of clinical pharmacology 71,5:589601. Yaffee P, Osipov A, Tan C, et al. (2015). Review of systemic therapies for locally advanced and metastatic rectal cancer. Journal of Gastrointestinal Oncology 6,2:185-200. Yoshida M, Muro K, Tsuji A, et al. (2015). Combination chemotherapy with bevacizumab and S-1 for elderly patients with metastatic colorectal cancer (BASIC trial). European journal of cancer 51,8:935-941. Pathology, Staging, Polymorphisms & Biomarkers Dodou D and de Winter JC. (2015). Agreement between self-reported and registered colorectal cancer screening: a meta-analysis. European Journal of Cancer Care 24,3:286298. Healthcare Improvement Scotland. Bowel Screening Standards. March 2015 Kidney E, Berkman L, Macherianakis A, et al. (2015). Preliminary results of a feasibility study of the use of information technology for identification of suspected colorectal cancer in primary care: the CREDIBLE study. British journal of cancer 112,Suppl:S70-6. 4 GI Cancers, February 2015 Kirsty Coltart, Subject Librarian, NHSGGC Library Network Papadatos-Pastos D, Rabbie R, Ross P, et al. (2015). The role of the PI3K pathway in colorectal cancer. Critical Reviews in Oncology-Hematology 94,1:18-30. Pietrantonio F, Petrelli F, Coinu A, et al. (2015). Predictive role of BRAF mutations in patients with advanced colorectal cancer receiving cetuximab and panitumumab: a metaanalysis. European journal of cancer 51,5:587-594. Uppara M, Adaba F, Askari A, et al. (2015). A systematic review and meta-analysis of the diagnostic accuracy of pyruvate kinase M2 isoenzymatic assay in diagnosing colorectal cancer. World Journal of Surgical Oncology 13,1:48. Webber EM, Kauffman TL, O'Connor E, et al. (2015). Systematic review of the predictive effect of MSI status in colorectal cancer patients undergoing 5FU-based chemotherapy. BMC Cancer 15,156. Xu F, Xu L, Wang M, et al. (2015). The accuracy of circulating microRNA-21 in the diagnosis of colorectal cancer: a systematic review and meta-analysis. Colorectal Disease 17,5:O100-7. Prognosis, Survival & Risk Factors Badgwell B, Roy-Chowdhuri S, Chiang YJ, et al. (2015). Long-term survival in patients with metastatic gastric and gastroesophageal cancer treated with surgery. Journal of surgical oncology 111,7:875-881. Boyce M and Thomsen L. (2015). Gastric neuroendocrine tumors: prevalence in Europe, USA, and Japan, and rationale for treatment with a gastrin/CCK2 receptor antagonist. Scandinavian Journal of Gastroenterology 50,5:550-559. Haller DG, O'Connell MJ, Cartwright TH, et al. (2015). Impact of age and medical comorbidity on adjuvant treatment outcomes for stage III colon cancer: a pooled analysis of individual patient data from four randomized, controlled trials. Annals of Oncology 26,4:715-724. Hawkins NA, Berkowitz Z, Rodriguez J, et al. (2015). Examining Adherence With Recommendations for Follow-Up in the Prevention Among Colorectal Cancer Survivors Study. Oncology nursing forum 42,3:233-240. Husson O, Mols F, Fransen MP, et al. (2015). Low subjective health literacy is associated with adverse health behaviors and worse health-related quality of life among colorectal cancer survivors: results from the profiles registry. Psycho-oncology 24,4:478-486. Renfro LA, Grothey A, Kerr D, et al. (2015). Survival following early-stage colon cancer: an ACCENT-based comparison of patients versus a matched international general population+. Annals of Oncology 26,5:950-958. van Gijn W, van Stiphout RG, van de Velde CJ, et al. (2015). Nomograms to predict survival and the risk for developing local or distant recurrence in patients with rectal cancer treated with optional short-term radiotherapy. Annals of Oncology 26,5:928-935. Yang B, Jacobs EJ, Gapstur SM, et al. (2015). Active smoking and mortality among colorectal cancer survivors: the cancer prevention study II nutrition cohort. Journal of Clinical Oncology 33,8:885-893. 5 GI Cancers, February 2015 Kirsty Coltart, Subject Librarian, NHSGGC Library Network Radiotherapy & Imaging Cai PQ, Lv XF, Tian L, et al. (2015). CT Characterization of Duodenal Gastrointestinal Stromal Tumors. AJR.American Journal of Roentgenology 204,5:988-993. Calais J, Dubray B, Nkhali L, et al. (2015). High FDG uptake areas on pre-radiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for locally advanced oesophageal cancer. European Journal of Nuclear Medicine & Molecular Imaging 42,6:858-867. Freilich J, Hoffe SE, Almhanna K, et al. (2015). Comparative outcomes for three-dimensional conformal versus intensity-modulated radiation therapy for esophageal cancer. Diseases of the Esophagus 28,4:352-357. Goon P, Morrison V, Fearnhead N, et al. (2015). High resolution anoscopy may be useful in achieving reductions in anal cancer local disease failure rates. European Journal of Cancer Care 24,3:411-416. Mocellin S and Pasquali S. (2015). Diagnostic accuracy of endoscopic ultrasonography (EUS) for the preoperative locoregional staging of primary gastric cancer. Cochrane Database of Systematic Reviews 2,009944. Supportive Care & Symptom Management Bol N, Smets EM, Eddes EH, et al. (2015). Illustrations enhance older colorectal cancer patients' website satisfaction and recall of online cancer information. European Journal of Cancer Care 24,2:213-223. Ma LN and Zhang RL. (2015). Risk, diagnosis and treatment to postoperative delirium in elderly patients with gastrointestinal cancers. Hepato-gastroenterology 62,138:529-535. McGregor LM, von Wagner C, Vart G, et al. (2015). The impact of supplementary narrativebased information on colorectal cancer screening beliefs and intention. BMC Cancer 15,162. Mitchell G, Porter S and Manias E. (2015). A critical ethnography of communication processes involving the management of oral chemotherapeutic agents by patients with a primary diagnosis of colorectal cancer: study protocol. Journal of advanced nursing 71,4:922-932. Otto SJ, Korfage IJ, Polinder S, et al. (2015). Association of change in physical activity and body weight with quality of life and mortality in colorectal cancer: a systematic review and meta-analysis. Supportive Care in Cancer 23,5:1237-1250. Reis T, Khazzaka E, Welzel G, et al. (2015). Acute small-bowel toxicity during neoadjuvant combined radiochemotherapy in locally advanced rectal cancer: determination of optimal dose-volume cut-off value predicting grade 2-3 diarrhoea. Radiation Oncology 10,1:30. Smith SG, Raine R, Obichere A, et al. (2015). The effect of a supplementary ('gist-based') information leaflet on colorectal cancer knowledge and screening intention: a randomized controlled trial. Journal of Behavioral Medicine 38,2:261-272. Wong CK, Chen J, Yu CL, et al. (2015). Systematic review recommends the European Organization for Research and Treatment of Cancer colorectal cancer-specific module for measuring quality of life in colorectal cancer patients. Journal of clinical epidemiology 68,3:266-278. 6 GI Cancers, February 2015 Kirsty Coltart, Subject Librarian, NHSGGC Library Network Yoon SL, Grundmann O, Williams JJ, et al. (2015). Novel intervention with acupuncture for anorexia and cachexia in patients with gastrointestinal tract cancers: a feasibility study. Oncology nursing forum 42,2:E102-9. Yoshida Y, Hoshino S, Aisu N, et al. (2015). Can grade 2 neutropenia predict the risk of grade 3 neutropenia in metastatic colorectal cancer patients treated with chemotherapy?. Supportive Care in Cancer 23,6:1623-1627. Surgery Andersen P, Andersen LM and Iversen LH. (2015). Iatrogenic ureteral injury in colorectal cancer surgery: a nationwide study comparing laparoscopic and open approaches. Surgical endoscopy 29,6:1406-1412. Berho M, Narang R, Van Koughnett JA, et al. (2015). Modern multidisciplinary perioperative management of rectal cancer. JAMA Surgery 150,3:260-266. Bonjer HJ, Deijen CL, Abis GA, et al. (2015). A randomized trial of laparoscopic versus open surgery for rectal cancer. New England Journal of Medicine 372,14:1324-1332. Broholm M, Pommergaard HC and Gogenur I. (2015). Possible benefits of robot-assisted rectal cancer surgery regarding urological and sexual dysfunction: a systematic review and meta-analysis. Colorectal Disease 17,5:375-381. Chen WK, Ren L, Wei Y, et al. (2015). General anesthesia combined with epidural anesthesia ameliorates the effect of fast-track surgery by mitigating immunosuppression and facilitating intestinal functional recovery in colon cancer patients. International journal of colorectal disease 30,4:475-481. Heneghan HM, Martin ST and Winter DC. (2015). Segmental vs extended colectomy in the management of hereditary nonpolyposis colorectal cancer: a systematic review and meta-analysis. Colorectal Disease 17,5:382-389. Hu CY, Bailey CE, You YN, et al. (2015). Time trend analysis of primary tumor resection for stage IV colorectal cancer: less surgery, improved survival. JAMA Surgery 150,3:245-251. Kennedy E, Vella ET, Blair Macdonald D, et al. (2015). Optimisation of preoperative assessment in patients diagnosed with rectal cancer. Clinical Oncology (Royal College of Radiologists) 27,4:225-245. Kobayashi S, Ito M, Yamamoto S, et al. (2015). Randomized clinical trial of skin closure by subcuticular suture or skin stapling after elective colorectal cancer surgery. British Journal of Surgery 102,5:495-500. Lu C, Zhou S, Peng Z, et al. (2015). Quality of D2 lymphadenectomy for advanced gastric cancer: is laparoscopic-assisted distal gastrectomy as effective as open distal gastrectomy?. Surgical endoscopy 29,6:1537-1544. Ma CC, Li P, Wang LH, et al. (2015). The value of single-incision laparoscopic surgery for colorectal cancer: a systematic literature review. Hepato-gastroenterology 62,137:45-50. Matsuda K, Hotta T, Takifuji K, et al. (2015). Randomized clinical trial of defaecatory function after anterior resection for rectal cancer with high versus low ligation of the inferior mesenteric artery. British Journal of Surgery 102,5:501-508. Mobily M and Patel JA. (2015). Palliative percutaneous endoscopic gastrostomy placement for gastrointestinal cancer: Roles, goals, and complications. World Journal of Gastrointestinal Endoscopy 7,4:364-369. 7 GI Cancers, February 2015 Kirsty Coltart, Subject Librarian, NHSGGC Library Network Morino M, Risio M, Bach S, et al. (2015). Early rectal cancer: the European Association for Endoscopic Surgery (EAES) clinical consensus conference. Surgical endoscopy 29,4:755773. NICE. IPG514 Transanal total mesorectal excision of the rectum. March 2015 Shapiro M, Rashid NU, Whang EE, et al. (2015). Trends and predictors of resection of the primary tumor for patients with stage IV colorectal cancer. Journal of surgical oncology 111,7:911-916. Sun X, Yang C, Li K, et al. (2015). The impact of anesthetic techniques on survival for patients with colorectal cancer: evidence based on six studies. Hepato-gastroenterology 62,138:299-302. Sun ZC, Xu WG, Xiao XM, et al. (2015). Ultrasonic dissection versus conventional electrocautery during gastrectomy for gastric cancer: A meta-analysis of randomized controlled trials. European Journal of Surgical Oncology 41,4:527-533. van der Schaaf M, Johar A, Wijnhoven B, et al. (2015). Extent of lymph node removal during esophageal cancer surgery and survival. Journal of the National Cancer Institute 107,5: Please note that the journal articles you are accessing are subject to the terms and conditions imposed by the publisher, so there will be a limit on the number of articles an individual may download or print from a single issue of a journal. You can consult your local NHSGGC library with any queries. If you have any questions regarding this or any other library services please contact Library staff – contact details are at the beginning of the bulletin. Sources used for this bulletin: OVID MEDLINE, NICE, SIGN, Healthcare Improvement Scotland 8 GI Cancers, February 2015 Kirsty Coltart, Subject Librarian, NHSGGC Library Network